Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.


CSE:PHRX - Post by User

Pharmadrug Inc > BUZZ WILL FOLLOW TRIP NO WORRIES WE WILL BUST
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(271)
•••
Comment by InvestABCson Dec 09, 2020 12:13pm
67 Views
Post# 32067976

RE:BUZZ WILL FOLLOW TRIP NO WORRIES WE WILL BUST

RE:BUZZ WILL FOLLOW TRIP NO WORRIES WE WILL BUSTGlad you found your home bro... stop pumping on trip board. yes similarities, but buzz is buzz and trip is trip...

you are rooking yourself as usual. amg called, he wants his lunch now, but you have to pay bc he went bust on failed flip attempts...promised us trip pump was over and buzz was 7.5 today. you have some explaining to do!!!!! grrrr........

BUZZ and TRIP both the mooooooooooooooooooon!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities